France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Fransada yeni koronavirus peyvəndinin sınaqlarına başlanılır
Во Франции начинаются испытания новой вакцины от COVID-19
Latest News
13:06
NATO chief discusses Black Sea drone attacks with Bulgarian PM
Other countries
13:01
Laos expects Baku agreements to bolster bilateral ties, investments
Foreign policy
12:50
MP Tahir Mirkishili proposes establishment of Institute of Azerbaijanism
Domestic policy
12:47
Mauritius temporarily closes schools after night of unrest over police shooting
Other countries
12:39
Milli Majlis ratifies 2 agreements, 1 treaty between Azerbaijan, Kyrgyzstan
Milli Majlis
12:35
Pakistani ambassador meets with ASAN Service chairman
Foreign policy
12:34
Thongloun Sisoulith announces visits by Lao ministers to Azerbaijan
Foreign policy
12:29
President of Laos praises Azerbaijan's rapid development
Foreign policy
12:19
Visa gets Beijing's green light for bank card business
Other countries